Enlibio，Your biological research partner
！
Enlibio
Biotech
Co.,Ltd,Wuhan,China 2008-2022
R&D 14th year
Home
Home
Products
Nav
News
Nav
Contact Us
Nav
About Us
Nav
Distributors
Nav
Sitemap
Nav
Human ELISA Kits
Mouse ELISA kits
Rat ELISA kits
Other species ELISA kits
ELISA Kit Assist Reagents
ELISAs
Primary Antibody
Secondary Antibody
Industrial Antibody development
Antibody Development Services
Antibody Related Reagents
Western blot Reagents
Immunohistochemistry Reagents
Antibodies
Recombinant Proteins
Natural Proteins
Peptides
Protein service
Peptide service
Immunogens
Cell Line
Download Manual
Enlibio News
Biological abstract
Contact Us
Technical Support
Messages
About Us
Job Opportunity
Company structure
Picture show
Biological abstract
Evolution of synchronous female bilateral breast cancers and response to treatment
[ Biological abstract ]
2023-03-15
Non-canonical functions of SNAIL drive context-specific cancer progression
[ Biological abstract ]
2023-03-15
SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory
[ Biological abstract ]
2023-03-15
Single-cell transcriptome profiling of the stepwise progression of head and neck cancer
[ Biological abstract ]
2023-03-06
PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerabi
[ Biological abstract ]
2023-03-06
Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non
[ Biological abstract ]
2023-03-03
Structural mechanism for inhibition of PP2A-B56α and oncogenicity by CIP2A
[ Biological abstract ]
2023-03-03
Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma
[ Biological abstract ]
2023-03-03
Single-cell biological network inference using a heterogeneous graph transformer
[ Biological abstract ]
2023-02-27
Autophagy inhibition prevents lymphatic malformation progression to lymphangiosarcoma by decreasing
[ Biological abstract ]
2023-02-24
Reconstructing clonal tree for phylo-phenotypic characterization of cancer using single-cell transcr
[ Biological abstract ]
2023-02-24
Fluorinated polyamidoamine dendrimer-mediated miR-23b delivery for the treatment of experimental rhe
[ Biological abstract ]
2023-02-22
Extracellular vesicles released from macrophages modulates interleukin-1β in astrocytic and neuronal
[ Biological abstract ]
2023-02-22
Dual blockage of both PD-L1 and CD47 enhances the therapeutic effect of oxaliplatin and FOLFOX in CT
[ Biological abstract ]
2023-02-13
RIPK3 controls MAIT cell accumulation during development but not during infection
[ Biological abstract ]
2023-02-13
Polycomb deficiency drives a FOXP2-high aggressive state targetable by epigenetic inhibitors
[ Biological abstract ]
2023-02-06
Fucosylation of HLA-DRB1 regulates CD4+ T cell-mediated anti-melanoma immunity and enhances immunoth
[ Biological abstract ]
2023-02-06
Notch1 mutations drive clonal expansion in normal esophageal epithelium but impair tumor growth
[ Biological abstract ]
2023-02-06
Epigenomic charting and functional annotation of risk loci in renal cell carcinoma
[ Biological abstract ]
2023-01-30
The NFIB/CARM1 partnership is a driver in preclinical models of small cell lung cancer
[ Biological abstract ]
2023-01-30
Prev
1
2
3
...
62
Next
Tel:+86-027-87610298
Tel:
+86-027-87610297
mail:
info@enlibio.com
mail:
sale@enlibio.com
mail:
alex@enlibio.com
mail:
order@enlibio.com
Add:Room A11-329, 1st Floor, No.1, SBI Venture Street, Optics Valley, East Lake
New Technology Development Zone, Wuhan, China.
Certificate NO.:U18Q28010569R0S
